Commentary

A tricky interplay, indeed


 

Author’s response:

Thank you, Dr. Morcos, for your careful read of our article.

Despite the lack of evidence, some providers are still prescribing native vitamin D for their patients with chronic kidney disease for reasons unrelated to parathyroid hormone suppression.Regarding the discussion of 1,25-(OH)2 vitamin D, we are in agreement. In fact, the last sentence of our paragraph reads: “There are no data, however, confirming that 25(OH)D supplementation mitigates these outcomes.” We were simply calling attention to the fact that despite the lack of evidence, some providers are still prescribing native vitamin D for their patients with chronic kidney disease for reasons unrelated to parathyroid hormone suppression.

Karly Pippitt, MD,
on behalf of co-authors Heather Nyman, PharmD, BCPS;
Alisyn Hansen, PharmD, BCACP, CDE;
Karen Gunning, PharmD, BCPS, BCACP, FCCP

Salt Lake City, UT

Pages

Recommended Reading

European initiative unveils pediatric care recommendations
MDedge Family Medicine
Bone disease in patients with kidney disease: A tricky interplay
MDedge Family Medicine
SHARE initiative releases consensus-based JDM management recommendations
MDedge Family Medicine
Does knuckle popping lead to arthritis?
MDedge Family Medicine
Most children with JIA get different diagnosis as adults
MDedge Family Medicine
In lupus, optimize non-immunosuppressives to dial back prednisone
MDedge Family Medicine
Severe joint pain in adults with arthritis continues to rise
MDedge Family Medicine
Guideline: Supplemental, dietary calcium both heart safe
MDedge Family Medicine
Fibromyalgia management: A multimodal approach
MDedge Family Medicine
ERRATUM
MDedge Family Medicine

Related Articles